Over 200 abstracts will be featured at the AAPP Annual Meeting. Posters will be displayed Monday, April 8-Tueday, April 9, 2024. Students, pharmacists, and other health care professionals will man their posters on Monday while resident and fellow posters will be manned on Tuesday. A special thank you to the abstract reviewers who participated in making these selections.
Congratulations to the ten (10) award finalists in the running for five AAPP research awards in 2024. Award finalists will present their abstracts during the platform presentations on Sunday, April 7, at AAPP 2024. Winners for all categories will be announced on Sunday evening during the AAPP Forum.
Therapeutic Case Report Award Finalists
- Dozie Dike, PharmD, BCPP, Clinical Pharmacist Practitioner, Michael E. DeBakey VA Medical Center, Houston, TX
High-Dose Vilazodone for the Treatment of Major Depressive Disorder: A Case Report - Jessica Jones, PharmD, BCPP, Clinical Psychiatric Pharmacist, San Diego County Psychiatric Hospital, San Diego, CA
From Mute to Multilingual: Successful Treatment of Benzodiazepine-Refractory Chronic Catatonia with Memantine
Innovative Practices Award Finalists
- Audrey Abelleira, PharmD, BCPP, BCPS, Clinical Pharmacist Practitioner, VISN 1 Clinical Resource Hub, Orange, CT
Integration of a Psychiatric Clinical Pharmacist Practitioner into a Virtual Long-Term Opioid Therapy Reassessment Clinic - Leigh Anne Nelson, PharmD, BCPP, Professor, University of Missouri-Kansas City School of Pharmacy, Kansas City, MO
A Novel Advanced Pharmacy Practice Experience (APPE): Scientific Writing with a Focus in Psychiatric Pharmacotherapy
Original Research Award Finalists
- Kevin Kavanagh, PharmD, BCPP, Pharmacist, San Diego County Psychiatric Hospital, San Diego, CA
Do Discharge Medications Prevent Rehospitalization Following Short-Term Crisis Stabilization at a County Psychiatric Hospital? - Aaron Salwan, PharmD, MPH, BCPP, Clinical Pharmacy Specialist, Behavioral Health, Montefiore Nyack Hospital, Nyack, NY
'Tranq': Perceptions of Xylazine and Harm Reduction Practices Among People Receiving Treatment for Substance Use Disorders
Research Trainee Award Finalists
- Kristin Manley, PharmD, MHSA – PGY2 Psychiatric Pharmacy Resident, McLean Hospital and Massachusetts General Hospital, Belmont, MA
Psychotropic Stewardship: Review of Antipsychotic Polypharmacy at Discharge from a Free-standing Psychiatric Hospital - Michelle Yang, PharmD, PGY2 Psychiatric Pharmacy Resident, Medical University of South Carolina (MUSC) College of Pharmacy, Charleston, SC
Characterization of Flumazenil Utilization in Electroconvulsive Therapy
AAPP Foundation Strategic Goals Award Finalists
- Joseph Cusimano, PharmD, BCPP, Safety Evaluator, Division of Pharmacovigilance-I, U.S. Food and Drug Administration, Silver Spring, MD
Development and Validation of an Instrument to Assess Patient Experience of Pharmacist-led Patient Medication Education Groups - Allison Tiemann, PharmD, PGY2 Pharmacy Resident, Tulsa, OK
Comparison of Pharmacist-Led Outpatient Depression Management to Current Prescriber-Led Depression Management
